{"id":"romiplostim-plus-dexamethasone","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Thrombosis"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Insomnia"}]},"_chembl":{"chemblId":"CHEMBL1201832","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Romiplostim is a thrombopoietin receptor agonist that binds to the TPO receptor on megakaryocyte progenitor cells, stimulating platelet production. Dexamethasone is a corticosteroid that suppresses immune-mediated platelet destruction. The combination targets both platelet production and immune-mediated destruction in immune thrombocytopenia (ITP).","oneSentence":"Romiplostim stimulates thrombopoietin receptors to increase platelet production, while dexamethasone provides immunosuppressive and anti-inflammatory effects to treat immune thrombocytopenia.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:32:35.898Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Immune thrombocytopenia (ITP)"}]},"trialDetails":[{"nctId":"NCT05325593","phase":"PHASE3","title":"Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-12-02","conditions":"Primary Immune Thrombocytopenia","enrollment":129},{"nctId":"NCT06992128","phase":"PHASE2","title":"Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-05-22","conditions":"Primary Immune Thrombocytopenia (ITP)","enrollment":129},{"nctId":"NCT06658834","phase":"PHASE2","title":"A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2024-06-01","conditions":"Primary Immune Thrombocytopenia","enrollment":129},{"nctId":"NCT05861297","phase":"PHASE4","title":"Immune Thrombocytopenia Management in Adults","status":"UNKNOWN","sponsor":"Nahda University","startDate":"2020-05-05","conditions":"Immune Thrombocytopenia Purpura","enrollment":467},{"nctId":"NCT00299182","phase":"PHASE1, PHASE2","title":"Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-03","conditions":"Lymphoma","enrollment":50},{"nctId":"NCT04588194","phase":"PHASE2","title":"Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia","status":"UNKNOWN","sponsor":"David Gomez Almaguer","startDate":"2020-11-01","conditions":"Immune Thrombocytopenia, Thrombotic Thrombocytopenic Purpura","enrollment":12}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ROM + DEX"],"phase":"phase_3","status":"active","brandName":"romiplostim plus dexamethasone","genericName":"romiplostim plus dexamethasone","companyName":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","companyId":"fundaci-n-p-blica-andaluza-para-la-gesti-n-de-la-investigaci-n-en-sevilla","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Romiplostim stimulates thrombopoietin receptors to increase platelet production, while dexamethasone provides immunosuppressive and anti-inflammatory effects to treat immune thrombocytopenia. Used for Immune thrombocytopenia (ITP).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}